New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil

New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil

The use of already-approved drugs to treat new or alternative diseases has proved to be beneficial in medicine, because it reduces both drug development costs and timelines. Most drugs can be used to treat different illnesses, due their mechanisms of action are not restricted to one molecular target...

Full description

Bibliographic Details
Main Authors: Marian Cruz-Burgos, Alberto Losada-Garcia, Carlos D. Cruz-Hernández, Sergio A. Cortés-Ramírez, Ignacio Camacho-Arroyo, Vanessa Gonzalez-Covarrubias, Miguel Morales-Pacheco, Samantha I. Trujillo-Bornios, Mauricio Rodríguez-Dorantes
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
drug repurposing
sildenafil
PDE5 inhibitors
cGMP
cancer
therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.627229/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.627229/full

Similar Items